Results 91 to 100 of about 5,202 (155)

Design, structure-based optimization and antiviral evaluation of potent inhibitors for the macrodomain Mac1 of SARS-CoV-2

Nature Communications
Enzymatically active macrodomains of (+)ss-RNA viruses mediate immune evasion by countering ADP-ribosylation and are therefore promising druggable targets. Here we report testing of ADP / ADP-ribose analogues for their ability to inhibit Mac1 of SARS-CoV-
Maximilian Sandmann, Sahra Tajdar, Simon Sander, David Ruiz Carrillo, Benedikt Ganter, Celine Fischer, Marina Ocenas, Stefanie Etzold, Neele Pekarek, Julia Berger, Toni Luise Meister, Barbara Selisko, Bruno Canard, Joanna M. Watt, Ondřej Baszczyňski, Barry VL Potter, Maria Garcia Alai, Tidow Henning, Pfefferle Susanne, Chris Meier, Ralf Fliegert   +20 more
doaj   +1 more source

Synthesis and Biological Evaluation of Modified Peptide Derivatives Targeting the SARS-CoV‑2 Nsp3 Macrodomain (Mac1) Replication Domain. [PDF]

ACS Omega
Özmen Ö, Oruçoğlu B, Dingiş Birgül Sİ, Öztürk Civelek D, Gül Ş, Akdemir A, Sönmez F, Zengin Kurt B.   +7 more
europepmc   +1 more source

Cross-species transcriptomic integration reveals a MIRO1-mediated macrophage-T cell axis in glioma. [PDF]

Life Sci Alliance
Du Z, Li M, Bergsneider BH, Tsai AP, Cho KB, Kim LH, Choi J, Li G, Wyss-Coray T, Lim M, Wang X.   +10 more
europepmc   +1 more source

Structure, function, regulation, evolution, and therapeutic implications of PARP14. [PDF]

Genes Dev
Kar P, Đukić N, Ahel D, Ahel I.
europepmc   +1 more source

Correction for Pfannenstiel et al., "Identification of a series of pyrrolo-pyrimidine based SARS-CoV-2 Mac1 inhibitors that repress coronavirus replication". [PDF]

mBio
Pfannenstiel JJ, Duong MTH, Cluff D, Sherrill LM, Colquhoun I, Cadoux G, Thorne D, Pääkkönen J, Schemmel NF, O'Connor J, Saenjamsai P, Feng M, Parthasarathy S, Hageman MJ, Johnson DK, Roy A, Lehtiö L, Ferraris DV, Fehr AR.   +18 more
europepmc   +1 more source

Efficient Binding Affinity Estimation for Fragment-Based Compounds Using a Separated Topologies Approach. [PDF]

J Chem Inf Model
Caldaruse AM, Baumann HM, Mobley DL.
europepmc   +1 more source

Evolution of distinct subclones in a CALM-AF10-driven AML murine model results in leukemias with different phenotypes. [PDF]

Blood Neoplasia
Zandvakili N, Lee HM, Desai RH, Oryshchuk A, Browett PJ, Kakadia PM, Bohlander SK.   +6 more
europepmc   +1 more source

An Automated Workflow for Diagnosing Sampling Issues Caused by Slow Torsional Motions in Molecular Simulations. [PDF]

J Chem Inf Model
Osato M, Dabbous T, Mobley DL.
europepmc   +1 more source

Rewriting the viral script: post-translational modifications orchestrating SARS-CoV-2 pathogenesis and immune evasion. [PDF]

Front Microbiol
Qu J, Liu M, Zhou C.
europepmc   +1 more source

Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo. [PDF]

J Med Chem
Jaishankar P, Correy GJ, Matsui Y, Togo T, Rachman MM, Stevens MGV, Hantz ER, Zheng J, Diolaiti ME, Montano M, Taha TY, Rosecrans J, Pampel J, Krogan NJ, Shoichet BK, Ashworth A, Ott M, Fraser JS, Renslo AR.   +18 more
europepmc   +1 more source